GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon Henry Guyatt, Andrew David Oxman, Gunn Elisabeth Vist et al. · BMJ · 2008
Guidelines are inconsistent in how they rate the quality of evidence and the strength of recommendations. This article explores the advantages of the GRADE system, which is increasingly being adopted by organisations worldwide
Cited by 22,974 works. doi:10.1136/bmj.39489.470347.ad Open-access PDF
Authors
- Gordon Henry Guyatt
- Andrew David Oxman
- Gunn Elisabeth Vist
- Regina Kunz
- Yngve T Falck-Ytter
- Pablo Alonso‐Coello
- Holger Jens Schünemann
References
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
- A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
- Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group
- Quality of evidence
- The Cardiac Arrhythmia Suppression Trial
- Users’ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice
- Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease
- Aspirin and Reye Syndrome